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 Antimicrobial resistance was observed in C. difficile from food, compost and lawn. 
 Compost isolates were more often resistant to erythromycin and tetracycline. 
 Multidrug resistance was detected in four strains, all isolated from compost. 
 Similar resistance patterns were noted in environmental and human C. difficile. 
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ABSTRACT (250 words) 
We recently reported a high prevalence of Clostridium difficile in retail vegetables, compost 
and lawn in Western Australia (WA). The objective of this study was to investigate the 
antimicrobial susceptibility of previously isolated food and environmental C. difficile isolates 
of WA. A total of 274 C. difficile isolates from vegetables, compost and lawn were tested for 
susceptibility to a panel of 10 antimicrobial agents (fidaxomicin, vancomycin, metronidazole, 
rifaximin, clindamycin, erythromycin, amoxicillin/clavulanate, moxifloxacin, meropenem 
and tetracycline) using an agar incorporation method. Fidaxomicin was the most potent agent 
(MIC50/MIC90, 0.06/0.12 mg/L). Resistance to fidaxomicin and metronidazole was not 
detected, and resistance against vancomycin (0.7%) and moxifloxacin (0.7%) was low. 
However, 37.6% of isolates showed resistance to at least one agent and multidrug resistance 
was observed in 3.9% of the resistant isolates, all of which came from compost. A 
significantly greater proportion of compost isolates were resistant to clindamycin, 
erythromycin and tetracycline compared to food and/or lawn isolates. C. difficile RT 014/020 
showed more clindamycin resistance than other less common RTs (Chi-square p = 0.008). 
Contaminated vegetables, compost and lawn could be playing an intermediary role in the 
transmission of C. difficile from animals to humans. Environmental strains of C. difficile 
could also function as a reservoir for antimicrobial resistance genes of clinical relevance. This 
study provides a baseline for future surveillance of antimicrobial resistance in environmental 
C. difficile in Australia. (Word count = 228) 
 

















Clostridium difficile infection (CDI) is the leading cause of life-threatening infectious 
diarrhoea in humans, and a major public health issue in many developed countries [1]. 
C. difficile causes a wide range of symptoms, from mild diarrhoea to severe 
pseudomembranous colitis and, in rare cases, fulminant colitis that may lead to intestinal 
perforation or megacolon and sepsis [1]. The major risk factor for developing CDI is 
exposure to antimicrobials, particularly agents with activity against commensal bowel flora 
such as clindamycin, aminopenicillins, extended-spectrum cephalosporins and 
fluoroquinolones [1]. Since 2000, a substantial increase in the incidence of CDI has been 
observed worldwide, including community-associated CDI (CA-CDI). Currently, 
approximately 30% of all CDI cases in Australia are CA-CDI with no traditional risk factors 
such as hospital stay, previous antimicrobial use or old age/immune senescence [2].  
Some studies have reported genetically-related, and in some cases indistinguishable, 
C. difficile strains from animals and humans [3] suggestive of zoonotic transmission. 
However, most related isolates were separated by vast geographical distances and there was 
no known prior contact between hosts, making direct transmission unlikely. Thus, following 
the isolation of clinically important C. difficile strains from food and the environment, it has 
been hypothesised that some CA-CDI might be foodborne or that transmission from an 
environmental source occurs in some other way [4].  
Recently, we found a high prevalence of C. difficile on retail root vegetables (30.0%, 
30/100) [5], in compost (27.2%, 22/81) destined for use in farming and landscaping (S.C. 
Lim et al., unpublished), and in public lawns (58.5%, 182/311) [6] in Perth, Western 














transmission of CDI, especially CA-CDI. It is common practice in Australia to use 
composted animal manure as fertiliser for vegetable and lawn (turf) farming which could 
result in contamination of vegetables and lawn with C. difficile of animal origin and lead to 
genetically highly-related human CDI in the community.  
While human clinical isolates are occasionally surveyed for antimicrobial 
susceptibility, less is known about antimicrobial resistance in C. difficile from other sources. 
The aims of this study were to (i) determine the antimicrobial susceptibility of C. difficile 
isolated from food, compost and lawn to a panel of 10 antimicrobial agents, and (ii) compare 
the antimicrobial profile of these strains with published animal- and human-derived isolates 
from Australia. 
2. Materials and methods  
2.1. Bacterial isolates 
In 2015 and 2016, studies were carried out in WA to determine the prevalence of 
C. difficile in food and environmental sources. All C. difficile isolates from those studies (n = 
274) were tested in the current investigation: 56 from vegetables (43 from root vegetables [5] 
and 13 from imported vegetables and/or vegetables of unknown country of origin 
(unpublished data)), 36 from compost (unpublished data) and 182 from lawn [6]. The isolates 
had been characterised by toxin gene profiling and PCR ribotyping [5, 6] using a reference 
library consisting of a collection of 54 internationally recognised UK ribotypes (RTs) that 
included 15 reference strains from the European Centre for Disease Prevention and Control, 
and various RTs currently circulating in Australia assigned with internal nomenclature, 
prefixed with QX. A summary of the RTs, toxin gene profiles and sources of the 274 
C. difficile isolates is shown in Fig. 1. C. difficile RT 014 and 020 were grouped together due 














which is the most common RT isolated from Australian pigs and humans [3], was the most 
common food and environmental RT in the collection. The toxin profiles represented 
included A-B-CDT- (n = 145; 52.9%), A+B+CDT- (n = 117; 42.7%), A-B+CDT+ (n = 7; 
2.6%), A+B+CDT+ (n = 2; 0.7%), A-B-CDT+ (n = 2; 0.7%) and A-B+CDT- (n = 1; 0.4%). 
2.2. MIC determination by agar incorporation 
The minimum inhibitory concentrations (MIC) of a panel of 10 antimicrobial agents 
were determined by the agar incorporation method as described by the CLSI [7, 8]. The panel 
comprised first line CDI therapies vancomycin and metronidazole, as well as fidaxomicin, 
rifaximin, clindamycin, erythromycin, amoxicillin/clavulanate, moxifloxacin, meropenem 
and tetracycline. The clinical breakpoints for vancomycin and metronidazole were those 
recommended by EUCAST (http://eucast.org). For fidaxomicin, the European Medical 
Agency proposed breakpoint of 1 mg/L was used (report WC500119707, 
http://www.ema.europa.eu/). Rifaximin resistance (≥ 32 mg/L) was as described by 
O’Connor et al. [9] and the breakpoints for clindamycin, erythromycin, 
amoxicillin/clavulanate, moxifloxacin, meropenem and tetracycline were those provided by 
CLSI [8].  
2.3. Statistical analysis 
Kruskal-Wallis rank sum test and Dunn test were performed to compare the geometric 
mean of MICs between C. difficile of food, compost and lawn origins. Fisher’s exact test, 
Chi-square test and post hoc test were used to compare the resistance rates of C. difficile from 
different origins.  
3. Results  
Fidaxomicin was the most active agent, showing potent in vitro activity against all 














activity was superior to the recommended first-line treatment agents for CDI, vancomycin 
(MIC50/MIC90, 1/2 mg/L) and metronidazole (MIC50/MIC90, 0.25/0.5 mg/L). However, no 
metronidazole resistance was observed and only two (0.73%) isolates were resistant to 
vancomycin (MIC = 4 mg/L, resistant breakpoint > 2).  
Phenotypic resistance to at least one antimicrobial agent was observed in 103 (37.6%) 
of the 274 isolates, predominantly those from compost (14/36, 38.9%) and lawn (82/182, 
45.1%). Only 7/56 food isolates (12.5%) exhibited resistance. Multidrug resistance (MDR), 
defined as resistance to at least one agent in three or more antimicrobial categories, was 
observed in 4 (3.9%) of the 103 resistant isolates and all were of compost origin; one isolate 
each of QX 327 (A-B-CDT-), QX 140 (A-B-CDT-) and UK 046 (A+B+CDT-) were resistant 
to clindamycin (MIC = > 32 mg/L), erythromycin (MIC = > 256 mg/L) and tetracycline 
(MIC = 64 mg/L, 16 mg/L and 32 mg/L, respectively), and one isolate of UK 012 
(A+B+CDT-) was resistant to rifaximin (MIC = > 64 mg/L), erythromycin (MIC = > 256 
mg/L) and tetracycline (MIC = 64 mg/L). Almost one-third (4/14) of the resistant compost 
isolates were MDR.  
There was a significant association between the source of isolates and resistance to 
rifaximin (3.6% from food, 2.8% from compost, 0.0% from lawn; Fisher’s exact p = 0.037), 
clindamycin (7.1% from food, 30.6% from compost, 42.3% from lawn; Chi-square p = < 
0.0001), erythromycin (0.0% from food, 19.4% from compost, 1.1% from lawn; Fisher’s 
exact p = < 0.0001) and tetracycline (1.8% from food, 13.9% from compost and 1.1% from 
lawn; Fisher’s exact p = 0.002) (Table 1). Compared to food and lawn isolates, compost 
isolates were more often resistant to erythromycin (compost vs. food, post hoc test p = 0.001; 
compost vs. lawn, post hoc test p = 0.0002) and tetracycline (compost vs. food, post hoc test 
p = 0.049; compost vs. lawn, post hoc test p = 0.005) (Table 1). The proportion of lawn 














0.26); however, both were significantly higher than food isolates (food vs. compost, post hoc 
test p = 0.01; food vs. lawn, post hoc test p = < 0.0001). Susceptibility to fidaxomicin, 
vancomycin, metronidazole, amoxicillin/clavulanate, moxifloxacin and meropenem did not 
significantly vary between isolates from different sources. 
4. Discussion 
While there has been an increase in publications on the prevalence of C. difficile in 
food and the environment, few reports have investigated the antimicrobial susceptibility of 
isolates of C. difficile recovered [10, 11]. This study is the first to determine the antimicrobial 
resistance patterns of food and environmental C. difficile isolates in Australia.  
As macrolides and tetracycline-based antimicrobial agents constitute approximately 
40% (112.2 tonnes per year) of all antimicrobials used in Australian food animals [12], it was 
not surprising that C. difficile isolates from compost exhibit resistance to erythromycin and 
tetracycline. Although clindamycin is not approved for use in food animals, previous studies 
on animal C. difficile strains have frequently reported intermediate or resistant MICs of 
clindamycin [3, 13]. Our previous study on C. difficile RT 014 from pigs showed high (69%) 
non-susceptibility to clindamycin, erythromycin and tetracycline, and 100% susceptibility to 
fidaxomicin, vancomycin, metronidazole, rifaximin, amoxicillin/clavulanate, moxifloxacin 
and meropenem [3], in agreement with the resistance patterns of compost isolates in this 
study. These findings, taken together, support our theory that compost isolates are likely to be 
of animal origin as C. difficile spores will survive the composting process [14]. Although not 
indicative of transmission to humans, both compost and lawn isolates shared antimicrobial 
resistance/susceptibility patterns similar to those reported in human-derived isolates [15]. In 
2015, antimicrobial susceptibility testing was performed on 440 human C. difficile isolates 














susceptible to fidaxomicin (100%), vancomycin (100%), metronidazole (100%), rifaximin 
(100%), amoxicillin/clavulanate (100%), moxifloxacin (96.1%) and meropenem (99.5%); 
similar to the findings for food, compost and lawn isolates. Furthermore, C. difficile that 
causes human CDI in Australia has a high prevalence of clindamycin resistance (84.3%) [15]. 
In this study, both compost and lawn isolates had relatively high levels of clindamycin 
resistance with MICs comparable to isolates from humans (MIC50/MIC90, 8/> 32 mg/L; MIC 
range 0.5 – > 32 mg/L) [15]. Further studies using whole-genome sequencing are necessary 
to better determine the relatedness of these compost and lawn isolates with C. difficile 
isolated from humans, particularly in the community.  
C. difficile RT 014/020 is consistently one of the most frequently isolated toxigenic 
RTs in humans worldwide, including Australia [16-18]. Of public health interest, in this 
study, C. difficile RT 014/020 (35/78, 44.9%) exhibit significantly greater resistance to 
clindamycin, a reported risk factor for CA-CDI [19], compared to other less common RTs 
(54/196, 27.6%) (Chi-square p = 0.008). Furthermore, two of the four MDR isolates, RTs 012 
and 046 from compost, were toxigenic and RTs that have previously been associated with 
human CDI [17]. This suggests that environmental C. difficile could be a reservoir for 
antimicrobial resistance genes of clinical relevance. In addition, exposure to toxigenic and 
antimicrobial resistant food and environmental C. difficile poses a risk of infection to 
susceptible individual and re-infection of a resolved patient with a new strain of C. difficile 
while the gut microbiota is still compromised.  
Based on antimicrobial resistance patterns, the C. difficile strains from compost 
appeared quite different to strains from vegetables and lawn; with greater resistance to 
erythromycin, tetracycline and/or clindamycin. This may be a reflection of a sampling bias as 
it is possible that the compost used to fertilise the vegetables and lawn came from different 














the manure originally came from due to issues of confidentiality. Furthermore, the acquisition 
and loss of antibiotic resistance genes occurs readily in C. difficile in response to selective 
pressure, as C. difficile has a diverse and highly flexible accessory genome comprising a 
range of mobile genetic elements conferring resistance to macrolide/lincosamide 
[Tn6194/Tn5398 (ermB)] and tetracycline [Tn916/Tn5397 (tetM)], many of which are 
capable of inter- and intra-species transfer in vitro [1, 3, 20].
 
In summary, similarities in antimicrobial resistance/susceptibility patterns were 
observed between environmental C. difficile and those of animal and human origin. Future 
genomic studies are required to determine if these isolates do indeed originate from animals 
and are responsible for CA-CDI. Nevertheless, this study shows that food or the environment 
harbouring toxigenic C. difficile strains could be sources for CDI in the community. This 
study provides a baseline for future surveillance of antimicrobial resistance in food and 
environmental C. difficile in Australia. 
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Fig. 1. Origin of C. difficile RTs tested in this study (n = 274). RT others (*) QX 001 
(A+B+CDT-), QX 026 (A+B+CDT-), QX 067 (A-B-CDT-), QX 076 (A+B+CDT-), QX 121 
(A-B-CDT-), QX 122 (A-B-CDT-), QX 140 (A-B-CDT-), QX 274 (A+B+CDT+), QX 327 
(A-B-CDT-), QX 399 (A+B+CDT+), QX 409 (A+B+CDT-), QX 449 (A-B-CDT-), QX 463 
(A-B-CDT-), QX 519 (A+B+CDT-), QX 525 (A-B-CDT-), QX 546 (A-B-CDT-), QX 547 
(A-B+CDT+), QX 550 (A-B-CDT-), QX 597 (A-B-CDT-), QX 598 (A-B-CDT-), QX 599 
(A-B-CDT-), QX 600 (A-B-CDT+), QX 602 (A-B-CDT-), QX 603 (A-B-CDT-), QX 604 
(A-B-CDT-), QX 605 (A-B-CDT-), QX 606 (A-B-CDT-), QX 607 (A-B-CDT-), UK 005 
(A+B+CDT-), UK 009 (A-B-CDT-), UK 017 (A-B+CDT-), UK 018 (A+B+CDT-), UK 033 
(A-B-CDT+), UK 046 (A+B+CDT-), UK 064 (A+B+CDT-), UK 070 (A+B+CDT-), UK 077 



















Table 1 Summary MIC data of 274 C. difficile isolates from food, compost and lawn 
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FDX, fidaxomicin; VAN, vancomycin; MTZ, metronidazole; RFX, rifaximin; CLI, 
clindamycin; ERY, erythromycin; AMC, amoxicillin/clavulanate; MXF, moxifloxacin; 
MEM, meropenem; TET, tetracycline; MIC, minimum inhibition concentration; S, 
susceptible; I, intermediate; R, resistance; NR, non-resistance; GM, geometric mean. 
a 
Breakpoints are those recommended by EUCAST (http://eucast.org) based on the 
epidemiological cut-off values for the ‘wild-type’ population. 
b
 Breakpoints are those recommended for anaerobes by CLSI.
11 
c




 Resistance (≥ 1 mg/L) is recommended by EMA (report WC500119707, 
http://www.ema.europe.eu/). 
†















 GM is significantly lower than the other two origins (FDX, p < 0.0001; RFX, p < 0.005; 
CLI, p < 0.0001) 
§
 GM is significantly higher than the other two origins (MTZ, p < 0.0001; ERY, p < 0.005; 
AMC, p < 0.0001; TET, p < 0.0001) 
¶ 
GM is significantly higher than the lawn isolates, but not the food isolates (MEM, p < 
0.005) 
 
 
